UNSPSC 51172155: Anethole trithione or anetholetrithione

This classification denotes a phase ii enzymes inducer with the molecular formula C10H8OS3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QUY32964DJ, chemically known as 5-(p-methoxyphenyl)-3h-1,2-dithiole-3-thione but generally known as anethole trithione, which bears US NIH Compound Identifier 2194. European Medicines Agency schedules Anethole trithione in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12902MIG.

World Health Organization schedules anethole trithione in its Anatomical Therapeutic Chemical (ATC) Classification. SMILES: COC1=CC=C(C=C1)C2=CC(=S)SS2.

UNSPSC 51172155 Anethole trithione or anetholetrithione (Commodity) shows minimal alignment with recent state and local procurement activity. The three opportunities tagged to this code—offender drug testing services, therapeutic pharmacy direct-to-manufacturer prescriptions, and generic multi-source pharmaceutical supply—fall outside the scope of a narrowly defined pharmaceutical active ingredient. The Collin County Community Supervision and Corrections Department RFP 2026-327 (due July 23, 2026) solicits specimen collection and drug testing services with immunoassay screening and confirmatory analysis, not active pharmaceutical ingredients. The Texas Health and Human Services Commission RFI HHS0017013 seeks vendor capabilities for direct-to-manufacturer prescription fulfillment and pharmacy benefit administration, a program-management function distinct from ingredient procurement. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP S1070000015802 (due March 26, 2026) targets finished generic pharmaceuticals and OTC products for state and local government facilities, again not raw active ingredients. None of these solicitations describe procurement of anethole trithione itself or direct pharmaceutical manufacturing inputs.

State and local governments do not appear to be sourcing anethole trithione as a distinct commodity at present. The mismatch between the code's narrow pharmaceutical-ingredient definition and the broad healthcare-services and finished-product procurement activity tagged to it signals either miscoding or a category seeing no recent relevant state and local demand. Business development professionals should verify the code's relevance before allocating pursuit resources; activity under this Commodity code does not reflect meaningful opportunity in the targeted segment.